Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Latest Information Update: 28 Apr 2014
At a glance
- Drugs Gevokizumab (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors XOMA
- 03 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrial.gov record.
- 21 Jan 2014 New trial record